Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine

Sheffner AL (1963) The reduction in vitro in viscosity of mucoprotein solutions by a new mucolytic agent, N-acetyl-L-cysteine. Ann NY Acad Sci 106: 298?310

Millar A, Pavia D, Agnew JE, Lopez-Vidriero MT, Lauque D, Clarke W (1985) Effect of oral N-acetylcysteine on mucus clearance. Br J Dis Chest 79: 262?266

Grassi C, Morandini GC (1976) A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis. Eur J Clin Pharmacol 9: 393?396

Multicenter Study Group (1980) Long-term acetylcysteine in chronic bronchitis. A double-blind controlled study. Eur J Respir Dis 61 [Suppl 111]: 93?108

Boman G, Bäcker U, Larsson S, Melander B, Wåhlander L (1983) Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: Report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir Dis 64: 405?415

Prescott LF, Park J, Ballantyne A, Adriaenssens P, Proudfoot AT (1977) Treatment of paracetamol (acetaminophen) poisoning with N-acetalcysteine. Lancet 2: 432?437

Yarbro JW (ed) (1983) N-acetylcysteine (NAC): A significant chemoprotective adjunct. Proceedings of a symposium. Semin Oncol 10 [Suppl 1]: 1?92

Morgan LR, Holdiness MR, Gillen LE (1983) N-acetylcysteine: Its bioavailability and interactions with ifosfamide metabolites. Semin Oncol 10 [Suppl 1]: 56?61

Kågedal B, Källberg M, Mårtensson J (1984) Determination of non-protein-bound N-acetylcysteine in plasma by high-performance liquid chromatography. J Chromatogr 311: 170?175

Lewis PA, Woodward AJ, Maddock J (1985) Improved method for the determination of N-acetylcysteine in human plasma by high-performance liquid chromatography. J Chromatogr 327: 261?267

Cotgreave IA, Moldéus P (1987) Methodologies for the analysis of reduced and oxidised N-acetylcysteine in biological systems. Biopharm Drug Disp 8: 365?375

Johansson M, Westerlund D (1986) Determination of N-acetylcysteine, intact and oxidized in plasma by column liquid chromatography and post-column derivatization. J Chromatogr 385: 343?356

Sheffner AL, Medler EM, Bailey KR, Gallo DG, Mueller AJ, Sarett HP (1966) Metabolic studies with acetylcysteine. Biochem Pharmacol 15: 1523?1535

Rodenstein D, De Coster A, Gazzaniga A (1978) Pharmacokinetics of oral acetylcysteine: Absorption, binding and metabolism in patients with respiratory disorders. Clin Pharmacokinet 3: 247?254

Bonanomi L, Gazzaniga A (1980) Toxicological, pharmacokinetic and metabolic studies on acetylcysteine. Eur J Respir Dis 61 [Suppl 111]: 45?51

Borgström L, Kågedal B, Paulsen O (1986) Pharmacokinetics of N-acetylcystine in man. Eur J Clin Pharmacol 31: 217?222

Hakman M, Gabrielsson J (1986) Introduction to MAXFIT: A user's guide. Dept Biopharmaceutics and Pharmacokinetics, Uppsala University, Uppsala, Sweden

Sheiner LB, Beal SL (1985) Pharmacokinetic parameter estimates from several least squares procedures: superiority of extended least squares. J Pharmacokinet Biopharm 13: 185?201

Riegelman S, Collier P (1980) The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time. J Pharmacokinet Biopharm 8: 509?534

Gibaldi M, Perrier D (1982) Pharmacokinetics. Marcel Dekker, New York Basel

Cotgreave IA, Grafström RC, Moldéus P (1986) Modulation of pneumotoxicity by cellular glutathione and precursors. Bull Eur Physiopathol Respir 22: 263s-266s

Tee LBG, Boobis AR, Davies DS (1986) N-acetylcysteine for paracetamol overdose. Lancet 1: 331?332